Kenneth R. Fisher - Mar 23, 2022 Form 4 Insider Report for Bluejay Diagnostics, Inc. (BJDX)

Role
Chief Financial Officer
Signature
/s/ Kenneth Fisher
Stock symbol
BJDX
Transactions as of
Mar 23, 2022
Transactions value $
$0
Form type
4
Date filed
3/28/2022, 02:57 PM
Previous filing
Nov 15, 2021
Next filing
Apr 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BJDX Option (right to buy) Award +65K 65K Mar 23, 2022 Common Stock 65K $1.31 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Of the option grant, 5,000 shares were fully-vested on the Transaction Date and 60,000 shares will vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date.
F2 Issued in connection with the reporting person's employment with the Company.